Overview
Availability
- Associate Professor David Macfarlane is:
- Available for supervision
Works
Search Professor David Macfarlane’s works on UQ eSpace
2018
Journal Article
Prospective analysis of the utility of 18-FDG PET in Merkel cell carcinoma of the skin: A Trans Tasman Radiation Oncology Group Study, TROG 09:03
Poulsen, Michael, Macfarlane, David, Veness, Michael, Estall, Venessa, Hruby, George, Kumar, Mahesh, Pullar, Andrew, Tripcony, Lee and Rischin, Danny (2018). Prospective analysis of the utility of 18-FDG PET in Merkel cell carcinoma of the skin: A Trans Tasman Radiation Oncology Group Study, TROG 09:03. Journal of Medical Imaging and Radiation Oncology, 62 (3), 412-419. doi: 10.1111/1754-9485.12705
2018
Conference Publication
A randomized controlled study comparing treatment of gastro-entero-pancreatic neuroendocrine tumors (GEPNET) with 177Lu-DOTATATE alone and in combination with capecitabine
Van der Zwan, W., Wyld, D., Brabander, T., Teunissen, J., Kam, B., MacFarlane, D., Krenning, E., Kwekkeboom, D. and de Herder, W. (2018). A randomized controlled study comparing treatment of gastro-entero-pancreatic neuroendocrine tumors (GEPNET) with 177Lu-DOTATATE alone and in combination with capecitabine. 15th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Barcelona, Spain, 7 - 9 March 2018. Basel, Switzerland: S. Karger AG.
2015
Journal Article
A prospective study of the impact of fluorodeoxyglucose positron emission tomography with concurrent non-contrast CT scanning on the management of operable pancreatic and peri-ampullary cancers
Burge, Matthew E., O'Rourke, Nick, Cavallucci, David, Bryant, Richard, Francesconi, Alessandra, Houston, Kathleen, Wyld, David, Eastgate, Melissa, Finch, Robert, Hopkins, George, Thomas, Paul and Macfarlane, David (2015). A prospective study of the impact of fluorodeoxyglucose positron emission tomography with concurrent non-contrast CT scanning on the management of operable pancreatic and peri-ampullary cancers. HPB, 17 (7), 624-631. doi: 10.1111/hpb.12418
2015
Journal Article
Blood–brain barrier dysfunction following traumatic brain injury: correlation of Ktrans (DCE-MRI) and suvr (99mTc-DTPA SPECT) but not serum S100B
Winter, Craig, Bell, Christopher, Whyte, Timothy, Cardinal, John, Macfarlane, David and Rose, Stephen (2015). Blood–brain barrier dysfunction following traumatic brain injury: correlation of Ktrans (DCE-MRI) and suvr (99mTc-DTPA SPECT) but not serum S100B. Neurological Research, 37 (7), 599-606. doi: 10.1179/1743132815Y.0000000018
2014
Conference Publication
Success with Lutetium-177 DOTATATE therapy in Cushing's syndrome caused by functional pancreatic neuroendocrine tumor (pNET) with ectopic adrenocorticotropic hormone (ACTH) secretion refractory to concomitant everolimus, pasireotide and metyrapone
Chan, B. A., Wyld, D., Burge, M., Cuneo, R., Macfarlane, D. and Lee, K. (2014). Success with Lutetium-177 DOTATATE therapy in Cushing's syndrome caused by functional pancreatic neuroendocrine tumor (pNET) with ectopic adrenocorticotropic hormone (ACTH) secretion refractory to concomitant everolimus, pasireotide and metyrapone. 11th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Barcelona Spain, 5 - 7 March 2014. Basel, Switzerland: S. Karger AG.
2014
Conference Publication
Novel succinate dehydrogenase subunit B intronic mutation in an Australian kindred with variable clinical and imaging phenotype necessitating different treatment modalities including 131-I MIBG and 177-Lutetium DOTATATE
Lee, K., Conway, L., Burge, M., Wyld, D. and Macfarlane, D. (2014). Novel succinate dehydrogenase subunit B intronic mutation in an Australian kindred with variable clinical and imaging phenotype necessitating different treatment modalities including 131-I MIBG and 177-Lutetium DOTATATE. 11th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Barcelona, Spain, 5 - 7 March 2014. Basel, Switzerland: S. Karger AG.
2013
Conference Publication
Breath-hold low dose CT immediately following PET/CT enables good quality virtual bronchoscopy prior to EBUS guide sheath biopsy
Fielding, David, Bashirzadeh, Farzad, Smith, Jye, Garcia, Peter, Frecker, Sue and Macfarlane, David (2013). Breath-hold low dose CT immediately following PET/CT enables good quality virtual bronchoscopy prior to EBUS guide sheath biopsy. New York, NY, United States: Elsevier.
2013
Journal Article
The 'double pituitary hot spot' sign of skull base meningioma on gallium-68-labelled somatostatin analogue PET
Law, W.P., Fiumara, F., Fong, W. and MacFarlane, D.J. (2013). The 'double pituitary hot spot' sign of skull base meningioma on gallium-68-labelled somatostatin analogue PET. Journal of Medical Imaging and Radiation Oncology, 57 (6), 680-683. doi: 10.1111/1754-9485.12069
2012
Conference Publication
Treatment of metastatic neuroendocrine tumours with (Lu)-L-177-octreotate: experience at Royal Brisbane and Women's Hospital
Sharma, A., Burge, M., MacFarlane, D., McDade, H., Kemp, S. and Wyld, D. (2012). Treatment of metastatic neuroendocrine tumours with (Lu)-L-177-octreotate: experience at Royal Brisbane and Women's Hospital. Medical Oncology Group of Australia Incorporated Annual Scientific Meeting, Program and Abstracts: Targeting Cancer from Diagnosis to Cure & 5th Annual COGNO Annual Scientific Meeting , Brisbane, QLD, Australia, 8 – 10 August 2012. Chichester, West Sussex, United Kingdom: Wiley-Blackwell Publishing.
2011
Journal Article
Detection of Pulmonary Emboli With 99mTc-Labeled Anti-D-dimer (DI-80B3)Fab' Fragments (ThromboView)
Morris, Timothy A., Gerometta, Michael, Yusen, Roger D., White, Richard H., Douketis, James D., Kaatz, Scott, Smart, Richard C., Macfarlane, David and Ginsberg, Jeffrey S. (2011). Detection of Pulmonary Emboli With 99mTc-Labeled Anti-D-dimer (DI-80B3)Fab' Fragments (ThromboView). American Journal of Respiratory and Critical Care Medicine, 184 (6), 708-714. doi: 10.1164/rccm.201104-0624OC
2011
Journal Article
Pulmonary Emboli Imaging with 99mTc-labelled Anti-D-dimer (DI-80B3) Fab′ Followed by SPECT
Morris, Timothy A., Gerometta, Michael, Smart, Richard C., Eisenberg, Paul, Roach, Paul J., Tsui, Wendy W., Better, Nathan, Taubman, Kim L., Unger, Steven A. and Macfarlane, David (2011). Pulmonary Emboli Imaging with 99mTc-labelled Anti-D-dimer (DI-80B3) Fab′ Followed by SPECT. Heart, Lung and Circulation, 20 (8), 503-511. doi: 10.1016/j.hlc.2011.03.113
2011
Journal Article
Changes in 18F-fluorodeoxyglucose and 18F-fluorodeoxythymidine positron emission tomography imaging in patients with non-small cell lung cancer treated with erlotinib
Mileshkin, Linda, Hicks, Rodney J., Hughes, Brett G. M., Mitchell, Paul L. R., Charu, Veena, Gitlitz, Barbara J., Macfarlane, David, Solomon, Benjamin, Amler, Lukas C., Yu, Wei, Pirzkall, Andrea and Fine, Bernard M. (2011). Changes in 18F-fluorodeoxyglucose and 18F-fluorodeoxythymidine positron emission tomography imaging in patients with non-small cell lung cancer treated with erlotinib. Clinical Cancer Research, 17 (10), 3304-3315. doi: 10.1158/1078-0432.CCR-10-2763
2011
Journal Article
Compliance with PET acquisition protocols for therapeutic monitoring of erlotinib therapy in an international trial for patients with non-small cell lung cancer
Binns, David S., Pirzkall, Andrea, Yu, Wei, Callahan, Jason, Mileshkin, Linda, Conti, Peter, Scott, Andrew M., Macfarlane, David, Fine, Bernard M., Hicks, Rodney J. and OSI3926g Study Team (2011). Compliance with PET acquisition protocols for therapeutic monitoring of erlotinib therapy in an international trial for patients with non-small cell lung cancer. European Journal of Nuclear Medicine and Molecular Imaging, 38 (4), 642-650. doi: 10.1007/s00259-010-1665-0
2011
Conference Publication
Does the addition of FDG-PET to the standard pre-operative work up of pancreatic cancer change management - a prospective study
Burge, M., Houston, K. E., Francesconi, A., O'Rourke, N., Lee, J., Macfarlane, D., Wyld, D., Hopkins, G., Finch, R. and Nathanson, L. (2011). Does the addition of FDG-PET to the standard pre-operative work up of pancreatic cancer change management - a prospective study. European Multidisciplinary Cancer Congress on Integrating Basic and Translational Science, Surgery, Radiotherapy, Medical oncology, Advocacy and Care, Stockholm, Sweden, 23 - 27 September 2011. Elsevier: Oxford, United Kingdom.
2011
Conference Publication
(68)Ga-dotatate: synthesis, automation, and quality control
Stimson, D., Macfarlane, D., Combs, M. and Yordanov, A. (2011). (68)Ga-dotatate: synthesis, automation, and quality control. 41st Annual Scientific Meeting of the Australian and New Zealand Society of Nuclear Medicine, Darwin, NT, Australia, 14 ‐ 18 July 2011. Richmond, VIC, Australia: Wiley-Blackwell Publishing Asia.
2011
Conference Publication
Radiopeptide lite - an automated radiopeptide labelling system using disposable cassettes
Combs, M., Stimson, D., Yordanov, A. and Macfarlane, D. (2011). Radiopeptide lite - an automated radiopeptide labelling system using disposable cassettes. 41st Annual Scientific Meeting of the Australian and New Zealand Society of Nuclear Medicine, Darwin, NT, Australia, 14 ‐ 18 July 2011. Richmond, VIC, Australia: Wiley-Blackwell Publishing Asia.
2010
Conference Publication
Improved delineation of brain tumour margins using whole-brain track-density mapping
Rose, S., Crozier, S., Bourgeat, P., Dowson, N., Salvado, O., Raniga, P., Pannek, K., Coulthard, A., Fay, M., Thomas, P. and MacFarlane, D. (2010). Improved delineation of brain tumour margins using whole-brain track-density mapping. ISMRM-ESMRMB Joint Annual Meeting 2010: Clinical Needs and Technological Solutions, Stockholm, Sweden, 1-7 May 2010. New York, USA: International Society of Magnetic Resonance in Medicine.
2010
Conference Publication
Joint factor and kinetic analysis of dynamic FDOPA PET scans of brain cancer patients
Dowson, N., Bourgeat, P., Rose, S., Daglish, M., Smith, J., Fay, M., Coulthard A., Winter, C., MacFarlane, D., Thomas, P., Crozier, S. and Salvado, O. (2010). Joint factor and kinetic analysis of dynamic FDOPA PET scans of brain cancer patients. 13th International Conference on Medical Image Computing and Computer-Assisted Intervention, MICCAI 2010, Beijing, China, 20 - 24 September 2010. Heidelberg, Germany: Springer. doi: 10.1007/978-3-642-15745-5_23
2009
Journal Article
Phase I biodistribution and pharmacokinetic study of Lewis Y-targeting immunoconjugate CMD-193 in patients with advanced epithelial cancers
Herbertson, Rebecca A., Tebbutt, Niall C., Lee, Fook-Thean, MacFarlane, David J., Chappell, Bridget, Micallef, Noel, Lee, Sze-Ting, Saunder, Timothy, Hopkins, Wendie, Smyth, Fiona E., Wyld, David K., Bellen, John, Sonnichsen, Daryl S., Brechbiel, Martin W., Murone, Carmel and Scott, Andrew M. (2009). Phase I biodistribution and pharmacokinetic study of Lewis Y-targeting immunoconjugate CMD-193 in patients with advanced epithelial cancers. Clinical Cancer Research, 15 (21), 6709-6715. doi: 10.1158/1078-0432.CCR-09-0536
2009
Journal Article
Nesidioblastosis as a cause of focal pancreatic 111In-pentetreotide uptake in a patient with putative VIPoma: another differential diagnosis
Francesconi, Alessandra Bastian, Matos, Marco, Lee, Joseph C., Wyld, David K., Clouston, Andrew D. and Macfarlane, David (2009). Nesidioblastosis as a cause of focal pancreatic 111In-pentetreotide uptake in a patient with putative VIPoma: another differential diagnosis. Annals of Nuclear Medicine, 23 (5), 497-499. doi: 10.1007/s12149-009-0252-6
Funding
Past funding
Supervision
Availability
- Associate Professor David Macfarlane is:
- Available for supervision
Before you email them, read our advice on how to contact a supervisor.
Media
Enquiries
For media enquiries about Associate Professor David Macfarlane's areas of expertise, story ideas and help finding experts, contact our Media team: